1-8 of 8
Islam Mohamad Sadek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment cost per AE symptom-free day of asciminib and second-generation tyrosine kinase inhibitors in newly diagnosed patients with chronic myeloid leukemia

Free
Jennifer Vaughn, Nadine Zawadzki, Caroline Hardy, Gabriel Marquez, Gopi Madhav Bommidi, Poornima Sachin Dhobe, Sai Vasmi Gedala, Islam Mohamad Sadek, Jason Shafrin, David Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 2835.
https://doi.org/10.1182/blood-2025-2835
Published: 2025
Journal Articles

Real-world treatment patterns, outcomes, and unmet needs in patients with ph+ ALL receiving tyrosine kinase inhibitors in the United States: Emerging trends and the role of asciminib-based combinations

Free
Marlise Luskin, Andrea Damon, Emily McGovern, Dominick Latremouille-Viau, Annie Guerin, Carmine Rossi, Fredrick Kinkhead, Gabriel Marquez, David Wei, Islam Mohamad Sadek, Elias Jabbour
Journal: Blood
Blood (2025) 146 (Supplement 1): 5097.
https://doi.org/10.1182/blood-2025-5097
Published: 2025
Journal Articles

Indirect treatment comparison (ITC) of asciminib and dasatinib in newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP)

Free
Onyee Chan, Gabriel Marquez, Valentine Laizet, Rob Mingxin Liu, Gabriela Friedrich, Katerina Papadimitropoulou, Isabelle Lundqvist, Shaun Walsh, Emily McGovern, Islam Mohamad Sadek, David Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 4611.
https://doi.org/10.1182/blood-2025-4611
Published: 2025
Journal Articles

A comparison of real-world outcomes of asciminib versus ATP-competitive tyrosine kinase inhibitors as second-line treatment in patients with chronic myeloid leukemia in chronic phase

Free
Ehab Atallah, Islam Mohamad Sadek, Emily McGovern, Dominick Latremouille-Viau, Carmine Rossi, Remi Bellefleur, Nathan Gobeil, Gabriel Marquez, Annie Guerin, Daisy Yang, David Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 724.
https://doi.org/10.1182/blood-2025-724
Published: 2025
Journal Articles

The humanistic burden of patients with chronic myeloid leukemia (CML) treated with first line (1L) tyrosine kinase inhibitors (TKIs)

Free
Kelly Schoenbeck, Joan Clements, Karen Demairo, David Wei, Nisha Hazra, Cristina Constantinescu, Yan Meng, Dominick Latremouille-Viau, Gabriel Marquez, Daisy Yang, Andrea Damon, Islam Mohamad Sadek, Annie Guerin, Kathryn Flynn
Journal: Blood
Blood (2025) 146 (Supplement 1): 6388.
https://doi.org/10.1182/blood-2025-6388
Published: 2025
Journal Articles

Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Interim analysis (IA) efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of newly diagnosed (1L) patients (pts)

Free
Moshe Levy, David Andorsky, CelesteAnn Bremer, Joshua Zeidner, Neil Palmisiano, Steven McCune, Anthony Hunter, Zohra Nooruddin, Haifaa Abdulhaq, Vivian Oehler, Shaker Dakhil, Brian Mulherin, Gustavo Fonseca, Michael Heinrich, Omer Jamy, Paul Koller, Koji Sasaki, Islam Mohamad Sadek, Daisy Yang, Dramane Laine, John (randy) Sabo, Amanda Hall, Dheeraj Gianchandani, Michael Mauro, Jorge Cortes, Ehab Atallah
Journal: Blood
Blood (2025) 146 (Supplement 1): 3775.
https://doi.org/10.1182/blood-2025-3775
Published: 2025
Journal Articles

Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of patients (pts) with 1 prior tyrosine kinase inhibitor (TKI)

Free
Jorge Cortes, Ehab Atallah, David Andorsky, Marlise Luskin, Srinivas Tantravahi, Koji Sasaki, James Dugan, CelesteAnn Bremer, Vivian Oehler, Joshua Zeidner, Moshe Levy, Camille Abboud, Paul Koller, Bonnie Kiner-Strachan, Habte Yimer, Islam Mohamad Sadek, Daisy Yang, Dramane Laine, John (randy) Sabo, Bridget Cooper, Ennan Gu, Michael Mauro
Journal: Blood
Blood (2025) 146 (Supplement 1): 906.
https://doi.org/10.1182/blood-2025-906
Published: 2025
Journal Articles

Real-world analysis of asciminib as first-line therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A chart review Study in the United States

Free
Ehab Atallah, Islam Mohamad Sadek, Emily McGovern, Dominick Latremouille-Viau, Carmine Rossi, Remi Bellefleur, Gabriel Marquez, Annie Guerin, Daisy Yang, David Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 8178.
https://doi.org/10.1182/blood-2025-8178
Published: 2025